• 1
    Aebi S,Gelber S,Castiglione-Gertsch M,Gelber RD,Collins J,Thurlimann B,Rudenstam CM,Lindtner J,Crivellari D,Cortes-Funes H,Simoncini E,Werner ID, et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 2000; 355: 186974.
  • 2
    Hilsenbeck SG,Ravdin PM,de Moor CA,Chamness GC,Osborne CK,Clark GM. Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat 1998; 52: 22737.
  • 3
    Andersen KW,Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988; 27: 62743.
  • 4
    Storm HH. The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ 1991; 22036.
  • 5
    Rostgaard K,Holst H,Mouridsen HT,Lynge E. Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 2000; 11: 66974.
  • 6
    Westergaard T,Andersen PK,Pedersen JB,Olsen JH,Frisch M,Sorensen HT,Wohlfart J,Melbye M. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997; 89: 93947.
  • 7
    Rhodes A,Jasani B,Balaton AJ,Barnes DM,Miller KD. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol 2000; 53: 68896.
  • 8
    Overgaard M,Hansen PS,Overgaard J,Rose C,Andersson M,Bach F,Kjaer M,Gadeberg CC,Mouridsen HT,Jensen MB,Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337: 94955.
  • 9
    Overgaard M,Jensen MB,Overgaard J,Hansen PS,Rose C,Andersson M,Kamby C,Kjaer M,Gadeberg CC,Rasmussen BB,Blichert-Toft M,Mouridsen HT. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 16418.
  • 10
    Kroman N,Jensen MB,Wohlfahrt J,Mouridsen HT,Andersen PK,Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000; 320: 4749.
  • 11
    Therneau TM,Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer-Verlag, 2000.
  • 12
    Ferno M,Borg A,Johansson U,Norgren A,Olsson H,Ryden S,Sellberg G. Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study. Group Acta Oncol 1990; 29: 12935.
  • 13
    Saez S,Chouvet C. Influence of endogenous hormone levels on tumour estradiol and progesterone receptors. Recent Results Cancer Res 1984; 91: 1506.
  • 14
    Thorpe SM,Rose C. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology. Cancer Surv 1986; 5: 50525.
  • 15
    Early Breast Cancer Trialist's Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687717.
  • 16
    Goldhirsch A,Glick JH,Gelber RD,Coates AS,Thurlimann B,Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 156983.